11 unchanged sentences
Certificate of Designation for the Series B Preferred Stock
+Added: Amendment to Amended and Restated Certificate of Incorporation, as amended, dated November 14, 2022
+Added: Certificate of Designation for the Series C Preferred Stock
Amended and Restated Bylaws
−Removed: 001-33678 
−Removed: Form of Certificate of Designation for the Series C Preferred Stock
+Added: Description of Securities
Form of Warrant pursuant to the Services Agreement with TLF Bio Innovation Lab, LLC, dated May 13, 2020
Form of July 2020 Warrant
−Removed: Form of November 2021 Warrant
Form of Amended July 2020 Warrant
−Removed: Form of November 2021 Warrant (as amended)
+Added: Form of Amended November 2021 Warrant
Form of September 2022 Warrant (2020 participants)
−Removed: Form of September 2022 Warrant for (2021 participants)
+Added: Form of September 2022 Warrant (2021 participants)
Form of Series A-1 Long-Term Warrant
Form of Series A-2 Short-Term Warrant
−Removed: Form of 2020 Reprice Letter Agreement, dated September 9, 2022
−Removed: Form of 2021 Reprice Letter Agreement, dated September 9, 2022
−Removed: Form of Securities Purchase Agreement, dated September 9, 2022
+Added: Form of Original Issue Discount Secured Senior Convertible Debenture
+Added: Form of Series B-1 Long-Term Common Stock Warrant
+Added: Form of Series B-2 Short-Term Common Stock Warrant
+Added: Form of Warrant Amendment Agreement
+Added: Form of Securities Purchase Agreement*
+Added: Form of Security Agreement*
+Added: Form of Subsidiary Guarantee
+Added: Form of Voting Commitment
Form of Registration Rights Agreement
−Removed: Form of Participant Voting Commitment
−Removed: Form of Additional Voting Commitment
−Removed: Form of Leak-Out Agreement
Certification of the Principal Executive Officer of NovaBay Pharmaceuticals, Inc., as required by Rule 13a-14(a) or Rule 15d-14(a)
Certification of the Principal Financial Officer of NovaBay Pharmaceuticals, Inc., as required by Rule 13a-14(a) or Rule 15d-14(a)
−Removed: Certification by the Chief Executive Officer  
−Removed: of NovaBay Pharmaceuticals, Inc., as required by Rule 13a-14(b) or 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18  
−Removed: Certification by the Chief Financial Officer of NovaBay Pharmaceuticals, Inc., as required by Rule 13a-14(b) or 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18  
+Added: Certification by the Chief Executive Officer of NovaBay Pharmaceuticals, Inc., as required by Rule 13a-14(b) or 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C.
+Added: Certification by the Chief Financial Officer of NovaBay Pharmaceuticals, Inc., as required by Rule 13a-14(b) or 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C.
Inline XBRL Instance Document
5 unchanged sentences
The Cover Page Interactive Data File, formatted in Inline XBRL (included within the Exhibit 101 attachments)
−Removed: * Certain confidential portions of this exhibit were omitted by means of marking such portions with brackets because the confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.
−Removed: ** These documents are not currently effective and will be entered into and become effective only if the 2022 Private Placement is completed.
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: November 14, 2022
/s/   Justin Hall 
2 unchanged sentences
(principal executive officer)
−Removed: November 14, 2022
−Removed: /s/   Andrew Jones 
−Removed: Chief Financial Officer
+Added: /s/   Tommy Law
+Added: Interim Chief Financial Officer
(principal financial officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.